跳至主要内容
临床试验/NCT01966484
NCT01966484已完成不适用

Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy

Dr. Horst Schmidt Klinik GmbH1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Intubating condition

研究概览

简要总结

Succinylcholine is commonly used for neuromuscular relaxation for short procedures such as rigid bronchoscopy. A alternative is the application of low dose mivacurium, reversed with neostigmine. The investigators compare the intubating conditions, incidence of postoperative myalgia (POM), patient satisfaction and the postoperative performance with respiration exercise device for these two muscle relaxants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 yr
  • scheduled for elective rigid bronchoscopy

排除标准

  • known neuromuscular disease
  • significant hepatic or renal dysfunction
  • family history of malignant hyperthermia
  • known allergy to one of the drugs used in this protocol
  • pregnancy or breastfeeding

研究组 & 干预措施

Succinylcholine

Active Comparator

Patient receive succinylcholine as a muscle relaxant (0,5mg/kg) after induction of general anaesthesia for rigid bronchoscopy.

干预措施: Succinylcholine (Drug)

Mivacurium

Active Comparator

Patients receive mivacurium (0,08mg/kg) as a muscle relaxant after induction of general anaesthesia for rigid bronchoscopy. At the end of the procedure and a twitch of 25% mivacurium was reversed with neostigmine (50 microg/kg) and atropin (10 microg/kg)

干预措施: Mivacurium (Drug)

结局指标

主要结局

Intubating condition

时间窗: After induction of general anaesthesia (after 3-5 minutes)

For measuring the intubation conditions the scoring system proposed for Good clinical Research Practice using the following variables is used: conditions of inserting the rigid bronchoscope, vocal cord position and coughing

次要结局

  • Postoperative Myalgia(72 hours after intervention)
  • postintervention performance with a expiration exercise device(72 hours after intervention)

研究者

发起方
Dr. Horst Schmidt Klinik GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验